Neurocrine Biosciences’ (NBIX) CEO Kevin Gorman on Deutsche Bank 39th Annual Health Care Conference (Transcript)

[at Seeking Alpha] – We discovered and developed the drug we took it through Phase I’s and multiple Phase II studies here. We had studied over 450 patients, in the Phase I and we will – once Abbvie is done with the drug have … more

View todays social media effects on NBIX

View the latest stocks trending across Twitter. Click to view dashboard

See who Neurocrine is hiring next, click here to view